Navigation Links
How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment

FARMINGTON, Conn., Sept. 13, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce a limited time offer on personalized medicine, next generation sequencing (NGS) and epigenetics research from Takeda Pacific, a bio/pharmaceutical and life sciences industry analyst firm based in California.


Personalized Medicine: Companies, Trends and World Market

The Personalized Medicine market includes significant core medical product areas that will continue to have a powerful impact on current and future healthcare delivery. The science driving personalized medicine includes pharmacogenetics, pharmacogenproteomics and pharmacometabalomix. Personalized medicine uses a targeted drug that depends on the patient information identified by a companion diagnostic (genetic biomarker test).

This report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Important technologies examined include: microarray, next-generation sequencing, polymerase chain reaction (PCR), bioinformatics, nanotechnology and other platforms. The report highlights new personalized diagnostics and also covers key biomarkers, commercial diagnostics and therapeutics that drive personalized medicine.

Save up to 20% by purchasing this report before October 15, 2012.

For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit

Epigenetics: Technologies, Drugs, Diagnostics, and World Market

Many people already know about DNA, genes and the human genome. The DNA code defines the structure of who we are, our potential health and our characteristics that we pass on to our children. Epigenetics refers to the second code of life and links environmental impacts to a person's health. Epigenetic mechanisms signal how and when genes are activated or silenced.

This research study discusses the market for life science tools and technologies that support epigenetics R&D. The report discusses important technologies, equipment and consumables including microarray, next-generation sequencing, PCR and other platforms. Topics such as microRNA and human stem cells are lightly covered.

This study discusses important epigenetics topics and provides the reader with key findings. The data estimates that the worldwide epigenetics market value will reach multi-billions of dollars in 2010, with a strong double-digit growth rate. This report reviews the activities of 35 companies. The study uses 39 figures and tables to illustrate the findings. This study includes many valuable tables that help the reader scan the details of major trends, market segmentation, forecast, M&As, partnerships, grant funding, patents and so on.

For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit

Next Generation Sequencing: Opportunities, Trends and World Market

This must-have report discusses the fast-growing worldwide market for next-generation sequencing (NGS) tools and services. Within a short time, the commercial NGS systems have seen a rapid uptake as these systems have been deployed into large genome centers, non-profit institutes, cancer research centers, drug makers, diagnostics firms and service providers worldwide. The report estimates that the total NGS tools and service market will reach $1.3 billion in 2011 and grow at a high double digit growth rate over the next 5-years. The report shows that various NGS systems are available to fill nearly every customer need, from high production volumes, to small scale, or to special niches.

For a detailed executive summary, sample charts, and table of contents, or to request free sample pages from the full report, please visit

Save up to 20% by purchasing any of these three reports before October 15, 2012.

About Global Information Inc. Global Information (GII) ( is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc.,, 1-860-674-8796,

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Molecular spectroscopy tracks living mammalian cells in real time as they differentiate
2. Global Biotech and Pharmaceutical Conference Early Bird Registration Discounts End This Week
3. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
4. Biological and Pharmaceutical Complex Fluids Conference
5. 7 pharmaceutical companies join academic researchers to speed TB drug discovery
6. AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms
7. Fish show autism-like gene expression in water with psychoactive pharmaceuticals
8. Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders
9. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
10. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
11. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
Post Your Comments:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts ... they believe could be a new and helpful biomarker for malignant pleural mesothelioma. ... here to read it now. , Biomarkers are components in the blood, ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
Breaking Biology Technology: